We are a leading developer and manufacturer of minimally invasive coronary stent systems, with one of the broadest product portfolios in the industry. We have a strong international presence with footprints in more than 65 countries.
We at SMT believe in continuous innovation and up-gradation of our portfolio in order to cater your healthcare needs. Our commitment is to advance the patient care by introducing state of the art medical devices which will enable us to save precious lives. We are committed to the welfare of all the patients around the world.
We are proud to be the first company to secure a CE mark for the biodegradable polymer-based drug eluting stents. Our portfolio includes drug eluting stents, bare metal stents, balloon catheters and inflation devices. Our aim is to expand our portfolio which will comprehensively cover all facets of cardiovascular treatment support.
We are committed to our philosophy “PLEDGED TO SAVE MILLIONS”.